Reevaluating Serologic Markers of Poor Prognostic Factors in Rheumatoid Arthritis.

Reevaluating Serologic Markers of Poor Prognostic Factors in Rheumatoid Arthritis. J Rheumatol. 2019 Apr 15;: Authors: Weinstein A, McEvilly B, Dervieux T Abstract The article by Alemao, et al 1 documented that acceleration of treatment regimens for 3458 biologic-naive patients with rheumatoid arthritis (RA) did not significantly differ based on the presence or absence of poor prognostic factors (PPF). These findings suggest that, for whatever reason, clinicians were unable to translate PPF into a more aggressive therapeutic approach. PMID: 30988124 [PubMed - as supplied by publisher]
Source: Journal of Rheumatology - Category: Rheumatology Tags: J Rheumatol Source Type: research